David W. Loring

20.4k total citations · 3 hit papers
340 papers, 14.5k citations indexed

About

David W. Loring is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, David W. Loring has authored 340 papers receiving a total of 14.5k indexed citations (citations by other indexed papers that have themselves been cited), including 179 papers in Cognitive Neuroscience, 175 papers in Psychiatry and Mental health and 66 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in David W. Loring's work include Epilepsy research and treatment (141 papers), Pharmacological Effects and Toxicity Studies (62 papers) and Neurobiology of Language and Bilingualism (59 papers). David W. Loring is often cited by papers focused on Epilepsy research and treatment (141 papers), Pharmacological Effects and Toxicity Studies (62 papers) and Neurobiology of Language and Bilingualism (59 papers). David W. Loring collaborates with scholars based in United States, United Kingdom and Australia. David W. Loring's co-authors include Kimford J. Meador, Muriel D. Lezak, Diane B. Howieson, Gregory P. Lee, Don W. King, Page B. Pennell, Gus A. Baker, Laura A. Kalayjian, Joyce Liporace and Joseph R. Smith and has published in prestigious journals such as New England Journal of Medicine, JAMA and NeuroImage.

In The Last Decade

David W. Loring

331 papers receiving 13.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neuropsychological assessment, 4th ed.

2004 1.6k citations David W. Loring et al. profile →
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs

2009 515 citations Kimford J. Meador, Gus A. Baker et al. profile →
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

2013 513 citations Kimford J. Meador, Gus A. Baker et al. profile →

Peers

Countries citing papers authored by David W. Loring

Since Specialization

Citations

This map shows the geographic impact of David W. Loring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Loring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Loring more than expected).

Fields of papers citing papers by David W. Loring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Loring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Loring. The network helps show where David W. Loring may publish in the future.

Co-authorship network of co-authors of David W. Loring

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Loring. A scholar is included among the top collaborators of David W. Loring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Loring. David W. Loring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Normative Performance for the Emory Complex Figure Scoring System and Recognition Task 2025 ·Archives of Clinical Neuropsychology ·(unknown), Robert J. Spencer, James J. Lah, Felicia C. Goldstein, David W. Loring	0
2	Would a rose by any other name smell as sweet? Complexity, context, and consequences of neuropsychology performance labels 2025 ·The Clinical Neuropsychologist ·David W. Loring, Bruce P. Hermann, Kimford J. Meador, James J. Lah, Felicia C. Goldstein, Robert M. Bilder	1
3	Comparison of minimally invasive to standard temporal lobectomy approaches to epilepsy surgery: Seizure relief and visual confrontation naming outcomes 2024 ·Epilepsy & Behavior ·(unknown), Kelsey C. Hewitt, Gregory P. Lee, (unknown), Cady Block, Nigel P. Pedersen, Jon T. Willie, David W. Loring, Mike R. Schoenberg, Kris A. Smith, Cole A. Giller, Robert E. Gross, Daniel L. Drane	5
4	The relevance of Spearman's g for epilepsy 2024 ·Brain Communications ·Aaron F. Struck, Camille Garcia‐Ramos, Veena A. Nair, Vivek Prabhakaran, Kevin Dabbs, Lisa L. Conant, Jeffrey R. Binder, David W. Loring, M. Elizabeth Meyerand, Bruce P. Hermann	0
5	The Montreal Cognitive Assessment: Norms and Reliable Change Indices for Standard and MoCA-22 Administrations 2024 ·Archives of Clinical Neuropsychology ·(unknown), (unknown), (unknown), Kelsey C. Hewitt, Christopher Nguyen, Robert J. Spencer, David W. Loring	3
6	Editorial 2023 ·Neuropsychology Review ·Stephen C. Bowden, David W. Loring	1
7	Patients with Cognitive Impairment in Parkinson's Disease Benefit from Deep Brain Stimulation: A Case‐Control Study 2023 ·Movement Disorders Clinical Practice ·Cady Block, (unknown), Benjamin B. Risk, (unknown), David W. Loring, Christine D. Esper, Laura Scorr, Lenora Higginbotham, (unknown), Mahlon R. DeLong, Thomas Wichmann, Stewart A. Factor, (unknown), Jon T. Willie, Nicholas M. Boulis, Robert E. Gross, Cathrin M. Buetefisch, Svjetlana Miocinovic	9
8	Computerized adaptive test strategies for the matrix reasoning subtest of the Wechsler Adult Intelligence Scale, 4th Edition (WAIS-IV) 2023 ·Journal of the International Neuropsychological Society ·Steven P. Reise, (unknown), (unknown), Keith F. Widaman, Joseph M. Gullett, Russell M. Bauer, Daniel L. Drane, David W. Loring, (unknown), Dustin Wahlstrom, (unknown), Fiona Whelan, (unknown), Robert M. Bilder	0
9	Development and application of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE): Initial results from a multi-center study of adults with temporal lobe epilepsy. 2022 ·Neuropsychology ·Carrie R. McDonald, Robyn M. Busch, Anny Reyes, (unknown), William Barr, Cady Block, Erik Hessen, David W. Loring, Daniel L. Drane, Marla J. Hamberger, Sarah J. Wilson, Sallie Baxendale, Bruce P. Hermann	45
10	The Georgia Memory Net: Implementation of a statewide program to diagnose and treat Alzheimer's disease and related dementias 2022 ·Journal of the American Geriatrics Society ·(unknown), (unknown), (unknown), (unknown), (unknown), John C. Morgan, (unknown), (unknown), Miranda A. Moore, (unknown), (unknown), Theodore M. Johnson, David W. Loring, Kenneth Hepburn, (unknown), Allan I. Levey, James J. Lah, Chadwick M. Hales	10
11	Relationships between frontal metabolites and Alzheimer's disease biomarkers in cognitively normal older adults 2021 ·Neurobiology of Aging ·Antoine Hone‐Blanchet, (unknown), Lisa C. Krishnamurthy, Syed Salman Shahid, Qixiang Lin, Liping Zhao, David W. Loring, Felicia C. Goldstein, Samantha E. John, Candace C. Fleischer, Allan I. Levey, James J. Lah, Deqiang Qiu, Bruce Crosson	7
12	Mood and quality of life in patients treated with brain-responsive neurostimulation: The value of earlier intervention 2021 ·Epilepsy & Behavior ·David W. Loring, Beata Jarosiewicz, Kimford J. Meador, Andrés M. Kanner, Tara L. Skarpaas, Martha J. Morrell	13
13	Vinpocetine, cognition, and epilepsy 2021 ·Epilepsy & Behavior ·Kimford J. Meador, (unknown), Alexandre E. Medina, Sílvia M. Illamola, (unknown), (unknown), (unknown), (unknown), Babak Razavi, Susan E. Marino, Alan Boyd, David W. Loring	18
14	Transitioning to telehealth neuropsychology service: Considerations across adult and pediatric care settings 2020 ·The Clinical Neuropsychologist ·Kelsey C. Hewitt, (unknown), David W. Loring, Alison E. Pritchard, Lisa A. Jacobson	53
15	2016 American Neuropsychiatric Association Annual Meeting Abstracts 2016 ·Journal of Neuropsychiatry ·(unknown), Aileen Chau, Jordan Grafman, (unknown), (unknown), (unknown), Victoria Bartlett, (unknown), (unknown), John R. Barry, David W. Loring, Kimford J. Meador, Lawrence Adler, José C. Álvarez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
16	IQ at 6 years after in utero exposure to antiepileptic drugs 2014 ·Neurology ·Gus A. Baker, Rebecca Bromley, (unknown), Christopher P. Cheyne, Morris J. Cohen, Marta García‐Fiñana, Alison Gummery, Rachel Kneen, David W. Loring, George Mawer, Kimford J. Meador, Rebekah Shallcross, Jill Clayton‐Smith, C. Barrie, John R. Beech, Alison Booth, Pete Dixon, Alan Fryer, (unknown)	166
17	Topiramate dose effects on cognition 2010 ·Neurology ·David W. Loring, (unknown), Kimford J. Meador, Frank Wiegand, Joseph Hulihan	80
18	Cognitive Function at Three Years of Age After Fetal Exposure to Antiepileptic Drugs 2009 ·Obstetrical & Gynecological Survey ·Kimford J. Meador, Gus A. Baker, N. Andrew Browning, Jill Clayton‐Smith, Deborah T. Combs‐Cantrell, Morris J. Cohen, Laura A. Kalayjian, Andrés M. Kanner, Joyce Liporace, Page B. Pennell, Michael Privitera, David W. Loring	0
19	Victoria Symptom Validity Test Performance in a Heterogenous Clinical Sample 2006 ·The Clinical Neuropsychologist ·David W. Loring, Glenn J. Larrabee, Gregory P. Lee, Kimford J. Meador	28
20	INTRACAROTID AMOBARBITAL PROCEDURE: The Wada Test 1995 ·Neuroimaging Clinics of North America ·Max R. Trenerry, David W. Loring	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact